(S)-5-butyl-9-(1-(4,6-dimethyl-2-(trifluoromethyl)pyrimidine-5-carbonyl)-4-methylpiperidin-4-yl)-3-((tetrahydro-2H-pyran-4-yl)methyl)-1-oxa-3,9-diazaspiro[5.5]undecan-2-one

ID: ALA1078713

PubChem CID: 46883030

Max Phase: Preclinical

Molecular Formula: C32H48F3N5O4

Molecular Weight: 623.76

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC1)CC2

Standard InChI:  InChI=1S/C32H48F3N5O4/c1-5-6-7-25-21-39(20-24-8-18-43-19-9-24)29(42)44-31(25)12-16-40(17-13-31)30(4)10-14-38(15-11-30)27(41)26-22(2)36-28(32(33,34)35)37-23(26)3/h24-25H,5-21H2,1-4H3/t25-/m0/s1

Standard InChI Key:  PBBNAVGXBQDIMO-VWLOTQADSA-N

Molfile:  

     RDKit          2D

 44 48  0  0  0  0  0  0  0  0999 V2000
   16.9333  -17.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3417  -18.0583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1583  -18.0609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5729  -17.3527    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1645  -16.6402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3417  -16.6359    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6805  -18.0233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5053  -18.0432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5397  -16.6180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7149  -16.5981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2830  -17.3030    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4604  -17.2817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0656  -16.5562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2444  -16.5356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8120  -17.2386    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2068  -17.9640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0341  -17.9865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9872  -17.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5559  -17.9200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5938  -16.4915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.7305  -17.8949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2993  -18.5973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6927  -19.3235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5218  -19.3428    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9493  -18.6397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7740  -18.6587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3387  -17.1689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9269  -18.7715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3371  -19.4873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9223  -20.2004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3325  -20.9162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5800  -15.9275    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.3979  -17.3565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8136  -16.6439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6371  -16.6509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0527  -15.9424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6470  -15.2237    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8211  -15.2179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4008  -15.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0417  -16.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2609  -20.0294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8693  -20.6698    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.4101  -20.1455    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.5469  -20.8427    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
 19 21  2  0
  1  9  1  0
 21 22  1  0
  9 10  1  0
 22 23  2  0
 10 11  1  0
 23 24  1  0
 12 13  1  0
 24 25  2  0
 25 19  1  0
  4  5  1  0
 25 26  1  0
  5  6  1  0
 21 27  1  0
  7  8  1  0
  2 28  1  6
 28 29  1  0
  1  2  1  0
 29 30  1  0
  1  6  1  0
 30 31  1  0
 12 17  1  0
  5 32  2  0
 13 14  1  0
  4 33  1  0
 14 15  1  0
 33 34  1  0
 34 35  1  0
 15 16  1  0
 16 17  1  0
 11 12  1  0
  2  3  1  0
 15 18  1  0
 34 39  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
  3  4  1  0
 12 40  1  0
 18 19  1  0
  7 11  1  0
 18 20  2  0
  8  1  1  0
 41 42  1  0
 41 43  1  0
 41 44  1  0
 23 41  1  0
M  END

Associated Targets(Human)

CCR5 Tclin C-C chemokine receptor type 5 (5640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 623.76Molecular Weight (Monoisotopic): 623.3658AlogP: 5.63#Rotatable Bonds: 7
Polar Surface Area: 88.10Molecular Species: BASEHBA: 7HBD:
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.17CX LogP: 3.20CX LogD: 1.43
Aromatic Rings: 1Heavy Atoms: 44QED Weighted: 0.39Np Likeness Score: -0.42

References

1. Rotstein DM, Gabriel SD, Makra F, Filonova L, Gleason S, Brotherton-Pleiss C, Setti LQ, Trejo-Martin A, Lee EK, Sankuratri S, Ji C, Derosier A, Dioszegi M, Heilek G, Jekle A, Berry P, Weller P, Mau CI..  (2009)  Spiropiperidine CCR5 antagonists.,  19  (18): [PMID:19674898] [10.1016/j.bmcl.2009.07.122]

Source